Lv0
0 积分 2025-05-07 加入
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
5天前
已完结
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
5天前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
5天前
已完结
Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease
5天前
已完结
Molecular and cellular mechanisms of liver fibrosis and its regression
5天前
已完结
Liver X receptors in lipid metabolism: opportunities for drug discovery
2个月前
已完结
HDL metabolism and function in diabetes mellitus
2个月前
已完结
Targeting RAS signalling pathways in cancer therapy
2个月前
已完结
Endoplasmic reticulum-mediated organelle crosstalk in kidney disease
4个月前
已完结
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
4个月前
已完结
皖公网安备34019202002308
